The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA moves toward easing restrictions on certain peptides BioPharma Dive As unregulated peptides grow in popularity, doctors warn of unknown risks ABC7 San Francisco Indictment of Osteopathic Physician Signals Shift in Peptide Enforcement Stevens & Lee